Skip to main content

Animations

MJFF Publications

1631 - 1640 of 8571 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2014
  • 2023
  • 2020
  • 2020
  • 2024
  • 2025
  • 2024
  • 2016
  • Summary Details
    OPEN
    Title: Alterations of PINK1-PRKN signaling in mice during normal aging
    Journal Name: Autophagy Reports
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/27694127.2024.2434379
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033
    Citation Count: 23
  • Summary Details
    OPEN
    Title: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a
    Journal Name: Journal of Neuroimmunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00526-9
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
    Journal Name: Molecular & Cellular Proteomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/mcp.ra120.002055
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00370
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00676-4
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00884-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.14244
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 925
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.